Levers Health review

Levers names its medical director and pharmacy and publishes prices before intake. Sermorelin is $297 one-time or $222 for a one-month subscription; NAD⁺ is $247 or $197. The GHK-Cu cream is $197 one-time or $157 on a one-month subscription. Its FAQ lists 41 states. Product pages say subscriptions can be canceled anytime, while the terms require at least two months and 48 hours’ notice before processing. Confirm the applicable commitment before ordering.

Levers Health LLC is a direct-to-consumer platform based in Scottsdale, Arizona and positioned as "personalized performance medicine", organized by goal — anti-aging, lean muscle, weight loss, more energy, better skin and hair. Its products are sermorelin, NAD⁺ injection, glutathione injection, lipotropic B-12 MIC+, a compounded GHK-Cu peptide skin cream, compounded semaglutide and tirzepatide, and a low-dose and microdose GLP-1 line marketed for longevity and metabolic optimization. Its about page names Russell Bartels, MD, a board-certified OB/GYN, as medical director. Every plan is described as reviewed and prescribed by a licensed physician in your state, with unlimited clinical support and check-in calls.

Choose a product, complete health-history forms, and receive a licensed physician review; Levers says it charges only after approval. Free shipping, a free introductory call and clinical support are advertised. Levers Health LLC lists a Scottsdale address, names Russell Bartels, MD as medical director, and identifies Strive Compounding Pharmacy in its terms. The FAQ lists 41 states, and the GHK-Cu product page uses the same list; product eligibility still needs confirmation at intake. Its terms say the site is operated in Arizona, without restricting shipments to Arizona. Product copy says cancel anytime, but the terms set a two-month subscription minimum and require cancellation at least 48 hours before processing. Orders are nonreturnable once placed with the pharmacy; the terms allow a refund before that stage. No mandatory patient lab schedule or price was established from the public pages.

Levers lists sermorelin at $297 one-time or $222 for a one-month subscription, and NAD⁺ at $247 or $197. Sermorelin also shows $188 per month for two months and $159 per month for four; NAD⁺ shows a $327 two-month charge ($163.50 per month), then $139 per month for four months and $129 per month for six. For its 30 g, 3.0% GHK-Cu cream, the one-month prices are $197 one-time or $157 on subscription. The cream page offers one-, two- and four-month sizes and says multi-month plans are prepaid but shipped one 30 g bottle monthly. For two and four months, Levers lists one-time totals of $394 and $788 and prepaid prices of $254 and $468. Confirm which longer plan is available at checkout and the amount charged before ordering. Glutathione injection is $187 one-time or $147 for one month. The semaglutide microdose is sold as a $246 two-month supply, advertised as $123 per month. Free shipping and an introductory call are advertised. Product pages say cancel anytime, while the terms impose at least two months and 48 hours’ cancellation notice.

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. Levers states in its own footer that medications including compounded options may be prescribed by independent physicians and fulfilled through a state-licensed pharmacy, and that the FDA does not review or approve compounded medications — the right disclosure, and its terms name Strive Compounding Pharmacy as the dispensing partner, though compounded sterile products are not reviewed by the FDA for purity and potency. On evidence: sermorelin is a GHRH analog that stimulates the pituitary to release your own growth hormone, preserving the feedback loop that exogenous HGH overrides — a real mechanism whose long-term human outcome data remains thin, which is worth weighing against a standing charge of $159 to $297 a month depending on the plan. Injected NAD⁺ has no controlled human outcome trials; the oral precursors NR and NMN are the forms with human data, and they raise blood NAD⁺ rather than demonstrating an outcome. GHK-Cu is a copper-binding tripeptide with an interesting laboratory story in collagen synthesis and wound repair and essentially no controlled human outcome trials — a 3.0% concentration is six times what the site says other clinics use, which raises the dose without supplying the missing evidence. Individual results vary.